Head Neck Cancer Clinical Trial
Official title:
Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer
Vibrent Health is partnering with Stanford Cancer Center to conduct a randomized control trial (RCT) using mobile health technology to enhance adherence and improve swallowing outcomes in patients undergoing radiation therapy for head and neck cancer.
Head and neck cancer (HNC) is the 6th most common type of cancer in the world and has recently seen a dramatic rise in the United States due to a rise in the incidence of oropharyngeal cancers related to the human papillomavirus (HPV) . The majority of patients diagnosed with HNC receive radiation therapy at some point in their treatment, either in the definitive or post-operative setting. Dysphagia is a common consequence of treatment for HNC, experienced by approximately 50% of patients treated with radiation therapy. Post-treatment dysphagia has been associated with increased risk of morbidity/mortality as well as well-recognized deterioration of quality of life. Performance of swallowing exercises during radiation significantly reduces dysphagia risk; however, patient adherence to swallowing exercises during radiation treatment is limited. Thus, poor adherence stands as a major obstacle to achieving the best swallowing outcomes. In response to this, a mobile health application was developed to directly address barriers cited by patients as reasons for non-adherence. The objective is to conduct a randomized controlled trial to test the impact of the mobile application on adherence to prophylactic swallowing therapy during radiation for HNC. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04566367 -
Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer
|
N/A | |
| Terminated |
NCT02521870 -
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05572684 -
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT02268344 -
Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection
|
N/A | |
| Terminated |
NCT00198328 -
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
|
Phase 3 | |
| Recruiting |
NCT04858269 -
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
|
Phase 2 | |
| Recruiting |
NCT05878964 -
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
|
||
| Recruiting |
NCT03051269 -
Calcium Electroporation for Head and Neck Cancer
|
Phase 1 | |
| Completed |
NCT05833841 -
Swallowing Function in Patients With Head and Neck Cancers
|
N/A | |
| Withdrawn |
NCT03747562 -
Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
|
Phase 3 | |
| Completed |
NCT03572829 -
Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC
|
Phase 2 | |
| Completed |
NCT02075385 -
Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer
|
Phase 2 | |
| Recruiting |
NCT02549742 -
Electrochemotherapy on Head and Neck Cancer
|
Phase 2 | |
| Completed |
NCT01951664 -
Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors
|
N/A | |
| Recruiting |
NCT05838729 -
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05382585 -
Newer Therapeutic Targets in Head and Neck Cancers
|